Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) — Stock Price
Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) is currently trading at CN¥12.78 CNY, up 1.51% today. Over the past 52 weeks, shares have ranged between CN¥11.40 and CN¥16.85. This page tracks Anhui Sunhere Pharmaceutical Excipients Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Anhui Sunhere Pharmaceutical Excipients .
Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Anhui Sunhere Pharmaceutical Excipients Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Anhui Sunhere Pharmaceutical Excipients Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥942.80 Million | CN¥882.57 Million | CN¥839.26 Million | CN¥704.53 Million | CN¥616.71 Million |
| Cost of Revenue | CN¥643.43 Million | CN¥609.34 Million | CN¥573.93 Million | CN¥495.28 Million | CN¥438.93 Million |
| Gross Profit | CN¥299.36 Million | CN¥273.23 Million | CN¥265.33 Million | CN¥209.24 Million | CN¥177.78 Million |
| Research & Development | CN¥42.27 Million | CN¥40.95 Million | CN¥41.95 Million | CN¥34.43 Million | CN¥26.80 Million |
| SG&A | CN¥18.18 Million | CN¥34.06 Million | CN¥31.34 Million | CN¥27.69 Million | CN¥30.67 Million |
| Total Operating Expenses | CN¥748.79 Million | CN¥129.96 Million | CN¥79.89 Million | CN¥72.96 Million | CN¥78.07 Million |
| Operating Income | CN¥194.00 Million | CN¥143.27 Million | CN¥185.44 Million | CN¥136.28 Million | CN¥99.71 Million |
| EBITDA | — | CN¥206.19 Million | CN¥228.90 Million | CN¥173.68 Million | CN¥132.56 Million |
| EBIT | — | CN¥155.51 Million | CN¥190.12 Million | CN¥137.62 Million | CN¥97.88 Million |
| Interest Expense | CN¥13.14 Million | CN¥13.15 Million | CN¥4.30 Million | CN¥1.61 Million | CN¥1.59 Million |
| Income Before Tax | CN¥198.68 Million | CN¥142.36 Million | CN¥185.82 Million | CN¥136.40 Million | CN¥96.68 Million |
| Income Tax Expense | — | CN¥21.83 Million | CN¥21.20 Million | CN¥5.47 Million | CN¥11.14 Million |
| Net Income | CN¥176.55 Million | CN¥119.42 Million | CN¥161.54 Million | CN¥130.71 Million | CN¥89.25 Million |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Anhui Sunhere Pharmaceutical Excipients Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥1.71 Billion | CN¥1.56 Billion | CN¥1.54 Billion | CN¥1.18 Billion | CN¥962.58 Million |
| Total Current Assets | CN¥1.15 Billion | CN¥1.02 Billion | CN¥939.37 Million | CN¥631.32 Million | CN¥552.82 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥521.55 Million | CN¥515.63 Million | CN¥511.77 Million | CN¥214.56 Million | CN¥187.88 Million |
| Net Receivables | CN¥129.32 Million | CN¥205.78 Million | CN¥146.16 Million | CN¥123.39 Million | CN¥129.53 Million |
| Inventory | CN¥92.26 Million | CN¥88.76 Million | CN¥94.10 Million | CN¥91.20 Million | CN¥77.77 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥305.04 Million |
| Goodwill | — | — | CN¥39.13 Million | CN¥39.13 Million | CN¥39.13 Million |
| Total Liabilities | CN¥639.20 Million | CN¥584.43 Million | CN¥607.46 Million | CN¥391.93 Million | CN¥256.67 Million |
| Total Current Liabilities | CN¥278.26 Million | CN¥233.47 Million | CN¥273.36 Million | CN¥345.25 Million | CN¥223.26 Million |
| Long-term Debt | CN¥309.19 Million | CN¥298.51 Million | CN¥287.59 Million | — | CN¥0.00 |
| Net Debt | CN¥15.29 Million | CN¥112.29 Million | CN¥123.64 Million | CN¥-110.28 Million | CN¥-110.23 Million |
| Total Stockholder Equity | CN¥1.01 Billion | CN¥905.01 Million | CN¥866.09 Million | CN¥722.52 Million | CN¥640.00 Million |
| Retained Earnings | CN¥577.44 Million | CN¥488.34 Million | CN¥441.68 Million | CN¥354.50 Million | CN¥344.85 Million |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Anhui Sunhere Pharmaceutical Excipients Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥191.99 Million | CN¥118.33 Million | CN¥142.84 Million | CN¥132.82 Million | CN¥103.82 Million |
| Capital Expenditures | CN¥40.73 Million | CN¥27.94 Million | CN¥54.92 Million | CN¥67.31 Million | CN¥31.47 Million |
| Free Cash Flow | CN¥151.26 Million | CN¥90.39 Million | CN¥77.38 Million | CN¥65.50 Million | CN¥72.35 Million |
| Investing Cash Flow | — | CN¥-15.01 Million | CN¥-332.98 Million | CN¥-88.21 Million | CN¥-19.84 Million |
| Financing Cash Flow | — | CN¥-85.21 Million | CN¥228.17 Million | CN¥-48.52 Million | CN¥-55.27 Million |
| Dividends Paid | CN¥71.43 Million | CN¥59.01 Million | CN¥59.78 Million | CN¥54.12 Million | CN¥45.10 Million |
| Stock-Based Compensation | — | — | CN¥258.35K | CN¥903.87K | CN¥3.84 Million |
| Depreciation | CN¥53.41 Million | CN¥50.75 Million | CN¥39.07 Million | CN¥36.06 Million | CN¥34.68 Million |
| Change in Cash | CN¥95.40 Million | CN¥19.33 Million | CN¥27.47 Million | CN¥-1.35 Million | CN¥28.43 Million |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Anhui Sunhere Pharmaceutical Excipients Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 24, 2026 | 0.19 | — | — |
| Oct 21, 2025 | 0.17 | — | — |
| Aug 27, 2025 | 0.19 | — | — |
| Apr 22, 2025 | 0.19 | — | — |
| Oct 22, 2024 | 0.12 | — | — |
| Aug 28, 2024 | 0.19 | — | — |
| Apr 25, 2024 | 0.21 | — | — |
| Oct 24, 2023 | 0.15 | — | — |